Top news
Stored first · Google News · Yahoo Finance (English)
- Motley Fool2026. 05. 31. 23:39
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million
- Investing.com Australia2026. 05. 26. 22:24
H.C. Wainwright reiterates Evommune stock rating on trial progress By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Evommune stock rating on trial progress By Investing.com Investing.com Australia
- Investing.com Nigeria2026. 05. 26. 21:05
H.C. Wainwright reiterates Evommune stock rating on trial progress By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Evommune stock rating on trial progress By Investing.com Investing.com Nigeria
- Investing.com UK2026. 05. 26. 20:42
H.C. Wainwright reiterates Evommune stock rating on trial progress By Investing.com - Investing.com UK
H.C. Wainwright reiterates Evommune stock rating on trial progress By Investing.com Investing.com UK
- Moomoo2026. 05. 26. 19:30
H.C. Wainwright Maintains Evommune(EVMN.US) With Buy Rating, Maintains Target Price $50 - Moomoo
H.C. Wainwright Maintains Evommune(EVMN.US) With Buy Rating, Maintains Target Price $50 Moomoo
- 富途牛牛2026. 05. 15. 16:00
Oppenheimer Maintains Evommune(EVMN.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
Oppenheimer Maintains Evommune(EVMN.US) With Buy Rating, Maintains Target Price $50 富途牛牛
